Stock Hero Advertisement
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

Fidelity says PVCT is invalid symbol now. Anyone

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
smt232 Member Profile
 
Followed By 0
Posts 41
Boards Moderated 0
Alias Born 01/15/14
160x600 placeholder
Advertisement
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/20/2015 6:04:59 AM
Provectus Biopharmaceuticals Opens Patient Enrollment; Begins Phase 3 International FDA Comparative Clinical Trial of PV-10 f... "Business Wire" - 4/15/2015 4:11:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/15/2015 4:04:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/8/2015 6:04:41 AM
Provectus Biopharmaceuticals to Present at 7th Annual International Partnering Conference, ChinaBio Partnering Forum 2015, Sh... "Business Wire" - 4/8/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/7/2015 6:04:28 AM
Provectus Biopharmaceuticals’ Data on PV-10 to Be Presented at HemOnc Today Melanoma and Cutaneous Malignancies Annual Meet... "Business Wire" - 4/7/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/2/2015 6:05:15 AM
Provectus Biopharmaceuticals Will Present at the Growth Capital Expo, Las Vegas at 1 pm PDT on Monday April 13, 2015 "Business Wire" - 4/2/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/20/2015 6:04:51 AM
Provectus Biopharmaceuticals Will Present at the 12th Annual BIO Asia International Conference Wednesday, March 25, 2015 "Business Wire" - 3/20/2015 6:00:00 AM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 3/16/2015 2:46:55 PM
Provectus Biopharmaceuticals’ Amended Protocol of PV-10 for Phase 3 Study as Treatment for Melanoma Now Available Online "Business Wire" - 3/16/2015 8:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/16/2015 6:11:42 AM
Provectus Biopharmaceuticals Updates Market on Business Developments "Business Wire" - 3/12/2015 8:21:00 AM
Provectus Biopharmaceuticals Awarded PH-10 Patent by U.S. Patent and Trademark Office "Business Wire" - 3/12/2015 8:12:00 AM
Provectus Biopharmaceuticals, Inc. Reports Fourth Quarter and Year End 2014 Results "Business Wire" - 3/12/2015 7:50:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/12/2015 7:12:21 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/12/2015 6:13:09 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2015 6:03:35 AM
Provectus Biopharmaceuticals Will Hold Its 2014 Year-End Quarterly Bus. Update Conference Call at 4 PM Eastern, Thursday, Mar... "Business Wire" - 2/24/2015 6:00:00 AM
Provectus Biopharmaceuticals Will Present at 8th Annual European Life Science CEO Forum & Exhibition "Business Wire" - 2/18/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/10/2015 6:03:50 AM
Provectus Biopharmaceuticals Will Present at 17th Annual BIO CEO And Investor Conference Tuesday, February 10, 2015 "Business Wire" - 2/10/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2015 6:10:05 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist